These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapy. Gasparini G, Bevilacqua P, Bonoldi E, Testolin A, Galassi A, Verderio P, Boracchi P, Guglielmi RB, Pezzella F. Clin Cancer Res; 1995 Nov; 1(11):1375-83. PubMed ID: 9815934 [Abstract] [Full Text] [Related]
7. A prospective study of p53 expression and its correlation with clinical response of radiotherapy in nasopharyngeal carcinoma. Ho KY, Kuo WR, Chai CY, Tsai SM, Sheu SH, Wu SC, Juan KH. Laryngoscope; 2001 Jan; 111(1):131-6. PubMed ID: 11192881 [Abstract] [Full Text] [Related]
9. [The expression of proliferating cell nuclear antigen and Bcl-2 oncoprotein in nasopharyngeal carcinoma]. Cheng Q, Huang X, Wang J. Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 Apr; 17(4):217-9. PubMed ID: 12838865 [Abstract] [Full Text] [Related]
10. Proliferating cell nuclear antigen, p53, and c-erbB-2 expression in relation to clinicopathological variables and prognosis in cancer of the ampulla of Vater. Ajiki T, Kamigaki T, Hasegawa Y, Fujino Y, Suzuki Y, Takeyama Y, Ku Y, Kuroda Y. Hepatogastroenterology; 2001 Apr; 48(41):1266-70. PubMed ID: 11677943 [Abstract] [Full Text] [Related]
12. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium. Mitselou A, Ioachim E, Kitsou E, Vougiouklakis T, Zagorianakou N, Makrydimas G, Stefanaki S, Agnantis NJ. In Vivo; 2003 Apr; 17(5):469-77. PubMed ID: 14598611 [Abstract] [Full Text] [Related]
13. Co-expression of p53 and bcl-2 may correlate to the presence of epstein-barr virus genome and the expression of proliferating cell nuclear antigen in nasopharyngeal carcinoma. Niemhom S, Kitazawa S, Murao S, Kunachak S, Maeda S. Cancer Lett; 2000 Nov 28; 160(2):199-208. PubMed ID: 11053650 [Abstract] [Full Text] [Related]
14. Correlation between proliferating cell nuclear antigen and p53 protein expression and 5-year survival rate in nasopharyngeal carcinoma. Wang LF, Chai CY, Kuo WR, Tai CF, Lee KW, Ho KY. Am J Otolaryngol; 2006 Nov 28; 27(2):101-5. PubMed ID: 16500472 [Abstract] [Full Text] [Related]
19. [Expression and clinical significance of IGF-II mRNA and bcl-2 protein in colorectal adenocarcinomas]. Zhang MS, Yuan HY, Xiong B, Deng Q, Tang ZJ, Xia D. Ai Zheng; 2002 Nov 28; 21(11):1226-30. PubMed ID: 12526221 [Abstract] [Full Text] [Related]